ADPT

Adaptive Biotechnologies Corporation

Price

$25.49

return (12m)

-49.26%

p/e

-61.38

p/bv

26.01

DIVIDEND YIELD

0.00%

ADPT price

Adaptive Biotechnologies

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ADPT

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

14.92%

3 months

-54.06%

1 year

-49.26%

2 years

32.48%

5 years

-79.12%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ADPT

Valuation

P/E

-61.38

Sector -2.19

Industry 1.21

P/BV

26.01

Sector 2.22

Industry 2.11

P/Revenue (PSR)

12.72

Sector 2.01

Industry 0.78

EV/EBITDA

-106.19

Sector -17.81

Industry -25.30

EV/EBIT

-104.96

Sector -26.72

Industry -18.04

P/EBITDA

-98.92

Sector 0.36

Industry 0.18

P/EBIT

-74.67

Sector -3.34

Industry 1.26

P/Total Assets

6.12

Sector 1.23

Industry 0.86

P/Net Current Assets

-56.42

Sector -27.35

Industry -12.37

P/Working Capital

11.77

Sector -4.54

Industry -49.48

EPS

-0.40

Sector -0.87

Industry -0.55

BVPS

0.94

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

75.58%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-51.46%

Sector -323.65%

Industry -73.39%

EBIT Margin

-52.06%

Sector -194.57%

Industry -11.94%

Operating Margin

-12.16%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-20.73%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.11

Sector 0.12

Industry 0.22

Profitability

ROE

-42.38%

Sector -33.82%

Industry -37.56%

ROA

-9.97%

Sector -29.63%

Industry -17.56%

ROIC

-21.90%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

4.79

Sector 1.84

Industry 1.14

Net Debt / EBITDA

0.25

Sector -1.47

Industry -31.86

Net Debt / EBIT

0.25

Sector -1.32

Industry 2.06

Net Debt / Equity

-0.06

Sector -0.35

Industry 0.14

Gross Debt / Equity

2.22

Sector 0.14

Industry 0.51

Equity/Assets

0.24

Sector 0.42

Industry 0.25

Liabilities/Assets

0.76

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

14.82%

Sector -

Industry -

5Y Earnings CAGR

-20.98%

Sector -

Industry -

Fundamentals ADPT

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ADPT Adaptive Biotechnologies Corporation	$25.49	-49.26%	0.00%	-61.38	26.01	-42.38%	-20.73%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ADPT Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Adaptive Biotechnologies

Adaptive Biotechnologies Corporation

Average Investor10 user rating

4.0 (3 people)

United States

17 years

Founded: 2009

2019

Time since IPO - 7 years

453

Employees

Adaptive Biotechnologies Corporation (United States) is listed on the Nasdaq and has a market capitalization of $3.92 billion, with shareholders equity totaling $150.66 million.

The company employs approximately 453 people and operates in the Health sector, within the Life Science Tools and Services industry.

Over the past 12 months, Adaptive Biotechnologies Corporation reported $308.07 million in revenue, generating net income of $-63.85 million.

Key financial metrics include a P/E ratio of -61.38, a price-to-book (P/B) ratio of 26.01, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ADPT.

Market cap

$3.92 billion

Net worth

$150.66 million

$150,660,000.00

Assets

$640.68 million

$640,680,000.00

Total Shares Outstanding

160.00 million

160,000,000

Average Daily Trading Volume

$3.23 million

$3,233,702.00

Sector

Health

Industry

Life Science Tools and Services

ADPT

ADPT revenue and profits

Financial Results ADPT

DRAG THE FRAME TO SEE MORE DATA

ADPT cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87